Filter By:

Drug delivery technique makes cancer immunotherapy more effective

Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.

After years of treatment and three relapses, CAR T-cell therapy offers hope for leukemia patient
New checkpoint inhibitor shows promise in clinical trial for non-Hodgkin’s lymphoma